A phase 2 trial of WF10 in patients with allergic rhinitis.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2015
At a glance
- Drugs WF 10 (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Acronyms 2015 WF10 Trial
- Sponsors Nuvo Research
- 21 Dec 2015 According to Nuvo Research media release, the company plans to discontinue this phase 2 trial.
- 21 Dec 2015 According to Nuvo Research media release, the company announce topline results of WF10 trial for the treatment of allergic rhinitis.
- 05 Aug 2015 According to Nuvo Research media release, status changed from not yet recruiting to active, no longer recruiting.